-
Merck and MPP sign licence deal for oral antiviral Covid-19 drug
Pharmaceutical-Technology
October 29, 2021
Merck (MSD) and the Medicines Patent Pool (MPP) have entered a voluntary licencing agreement to offer affordable international access for the former’s experimental oral antiviral, molnupiravir (MK-4482/EIDD-2801), to treat Covid-19.
-
Bharat Biotech’s US partner Ocugen files request with FDA for Covaxin trials
ExpressPharma
October 29, 2021
Ocugen, Bharat Biotech’s US partner for COVID-19 vaccine Covaxin, yesterday said it has submitted Investigational New Drug Application (IND) to the US Food and Drug Administration (FDA) to conduct clinical trials.
-
Nearly 59,000 Meatpacking Workers Caught COVID-19
Drugs
October 29, 2021
The number of U.S. meatpacking workers who were infected during the COVID-19 pandemic is nearly three times higher than previously thought, a U.S. House report shows.
-
Q&A: COVID-19 vaccine shots for children
NMPA
October 29, 2021
Giving children COVID-19 vaccine shots is an important part of building up immunity barrier for the entire population, as well as an important measure to block the spread of the COVID-19 virus.
-
Lithium-Ion Battery Recycling Market to Hit US$ 1,392.8 million by 2028; The Insight Partners
prnewswire
October 29, 2021
According to The Insight Partners study on "Lithium-Ion Battery Recycling Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Battery Chemistry, Application, and Geography," the market...
-
Immunocompromised May Need Fourth COVID-19 Shot: CDC
Drugs
October 28, 2021
Severely immunocompromised people may require a fourth mRNA COVID-19 shot, the U.S. Centers for Disease Control and Prevention says.
-
Launch of Seegene's STARlet-AIOS: All-in-One System Fulfills Critical Need for Fully Automated, High-Throughput Real-Time PCR Testing
prnasia
October 28, 2021
South Korea's leading molecular diagnostics (MDx) developer Seegene Inc., (KQ 096530) is addressing the needs of small, mid-sized, and large hospitals and COVID-19 laboratories with its fully automated STARlet-AIOS...
-
Horse hyperimmune antibody may help the fight against COVID-19
WorldPharmaNews
October 28, 2021
A study conducted by a consortium of Brazilian researchers has demonstrated that a hyperimmune serum consisting of purified antibody fragments produced in horses may be an efficient approach to combat COVID-19.
-
CyanVac eyes fundraise for parainfluenza-vectored Covid-19 vaccine after December data
Pharmaceutical-Technology
October 28, 2021
CyanVac expects its Phase I parainfluenza virus-vectored Covid-19 vaccine trial to have early data in December, which could be the impetus for a $30m fundraise.
-
Merck Allows Poor Nations to Make COVID-19 Pill
Drugs
October 28, 2021
A deal for the Merck COVID-19 pill to be made and sold cheaply in poor nations has been reached with Medicines Patent Pool, a United Nations-backed nonprofit organization.